Understanding Symptoms and Severity of New COVID-19 Variants Like Cerberus

Understanding the Latest COVID-19 Variants and Their Symptoms

As the COVID-19 pandemic continues into its third year, the virus behind the disease continues to evolve. New variants of SARS-CoV-2, the virus that causes COVID-19, emerge periodically with new mutations that can increase transmissibility, severity of illness, and ability to evade immune protection from past infection and vaccination.

One variant that rose to prominence recently is known as BQ.1 and BA.2 subvariants combined into one called the Cerberus. This combined variant has quickly become the dominant strain in the United States and many other countries around the world.

The Rise of the Cerberus Variant

The Cerberus variant first emerged in late 2022 as an offshoot of the Omicron variant, which drove a massive surge in cases throughout the winter 2021-2022 season. Cerberus combines traits of BA.2, an Omicron sub-variant, along with new mutations in the BQ.1 and BQ1.1 strains.

Public health officials have been closely monitoring the rapid increase in Cerberus infections. By the end of November 2022, Cerberus accounted for over 30% of new COVID-19 infections in the U.S. By late December 2022, it comprised over 75% of sequenced cases.

Experts credit the variant's mutations that enable greater transmissibility and immune evasion as reasons why it outpaced other strains. The mutations appear to make the virus even more adept at infecting human cells and avoiding antibodies from vaccination and prior infection.

Symptoms Linked to Cerberus Infection

Thus far, there is no evidence that infection with the Cerberus variant causes more severe symptoms or outcomes compared to earlier forms of Omicron. Most infections, particularly in vaccinated individuals, result in cold-like respiratory and general symptoms.

Common symptoms linked to Cerberus infection based on emerging data include:

• Runny or stuffy nose
• Fatigue
• Sneezing
• Sore throat
• Persistent cough

While similar to early Omicron infection for many people, there are still risks of severe disease with Cerberus, particularly for unvaccinated, immunocompromised, elderly, or medically vulnerable groups.

Comparing Severity to Other Variants

Despite rising to account for an overwhelming majority of U.S. cases, national hospitalization rates for severe COVID-19 illness actually started to decline in late 2022. Experts believe widespread previous exposures to Omicron subvariants have provided a degree of protection against severe Cerberus disease.

However, some localized regions have reported recent increases in numbers of infected patients requiring hospital care. Continued monitoring for shifts in severity indicators remains important as Cerberus cases accumulate globally.

In terms of case severity, early evidence indicates infection with Cerberus produces less severe outcomes on average compared to earlier dominant variants like Delta and the original SARS-CoV-2 strain.

Vaccination remains highly effective at preventing hospitalization and death associated with Cerberus infection. However, immunity from vaccines wanes over time, underlining the importance of bivalent booster shots targeting Omicron subvariants.

Outlook for New Variants and Ongoing Precautions

The past three years highlight that SARS-CoV-2 will continue evolving new variants that present fresh challenges for managing pandemic spread. Even after infection numbers decline from future peaks, COVID-19 will likely circulate seasonally for years.

New variants will also keep emerging in the post-Omicron period. Scientists closely track signals of rising new mutants with concerning traits, including the XBB subvariants spreading rapidly in parts of Asia.

As long as the virus spreads, it mutates and potentially spins off fitter variants. Getting more people vaccinated and boosted globally remains vital to limiting opportunities for problematic new variants to develop.

In the meantime, tried and true protective measures retain importance:

• Staying up-to-date on COVID-19 vaccinations
• Wearing well-fitting masks in crowded indoor settings
• Seeking testing and isolating when sick
• Improving indoor ventilation

Paying attention to public health guidance, especially at local levels, can help individuals understand when to take extra precautions based on COVID-19 community levels and transmission trends.

While pandemic fatigue is understandable after close to three years living with COVID-19, we must continue supporting public health measures and vaccinations. Remaining vigilant and responsive in the face of inevitable new variants gives us the best chance at managing spread to protect societal wellbeing.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new treatment regimen.